Pyridazino[3,4-b][1,5]benzodiazepin-5-ones: Synthesis and biological evaluation

Antiviral Chemistry and Chemotherapy

Volumn 8, Issue 4, 1997, Pages 371-379

  Heinisch, G ^a   Huber, E ^a   Leitner, C ^a   Matuszczak, B ^a   Maurer, A ^a   Pachler, S ^a   Prillinger, U ^a  

^a UNIVERSITY OF INNSBRUCK   (Austria)

Author keywords

HIV; Non nucleosides; Pyridazino 3,4 b 1,5 benzodiazepin 5 ones; Reverse transcriptase inhibitors

Indexed keywords

ANTI HUMAN IMMUNODEFICIENCY VIRUS AGENT; NEVIRAPINE; PYRIDAZINO[3,4 B][1,5]BENZODIAZEPIN 5 ONE DERIVATIVE; RNA DIRECTED DNA POLYMERASE; RNA DIRECTED DNA POLYMERASE INHIBITOR; UNCLASSIFIED DRUG; VIRUS ENZYME;

ANTIVIRAL ACTIVITY; ARTICLE; CONTROLLED STUDY; DRUG SCREENING; DRUG STRUCTURE; DRUG SYNTHESIS; ENZYME INHIBITION; HUMAN IMMUNODEFICIENCY VIRUS 1; PRIORITY JOURNAL; STRUCTURE ACTIVITY RELATION;

EID: 0030745010     PISSN: 09563202     EISSN: None     Source Type: Journal    
DOI: 10.1177/095632029700800410     Document Type: Article

References (15)

1. Adams J & Merluzzi VJ (1993) Discovery of nevirapine, a nonnucleoside inhibitor of HIV-1 reverse transcriptase. In The Search for Antiviral Drugs. Edited by J Adams & VJ Merluzzi. Basel, Berlin & Boston: Birkhäuser, pp. 45-70.
2. Barth B, Dierich M, Heinisch G, Jenny V, Matuszczak B, Mereiter K, Planer R, Schöpf I, Stoiber H, Traugott T & vAufschnaiter PV (1996) Pyridazino[3, 4-b][1, 5]benzoxazepin-5(6H)-ones: synthesis and biological evaluation. Antiviral Chemistry and Chemotherapy 7: 300-312.
3. Cohen KA, Hopkins J, Ingraham RH, Pargellis C, Wu JC, Palladino DEH, Kinkade P, Warren TC, Rogers S, Adams J, Farina PR & Grob PM (1991) Characterization of the binding site for nevirapine (BI-RG-587), a nonnucleoside inhibitor of human immunodeficiency virus type-1 reverse transcriptase. Journal of Biological Chemistry 266: 14670-14674.
4. De Clercq E (1994a) Non-nucleoside reverse transcriptase inhibitors (NNRTIs). Expert Opinion in Investigational Drugs 3: 253-271.
5. De Clercq E (1994b) Resistance of human immunodeficiency virus type 1 (HIV-1) to non-nucleoside HIV-1-specific reverse transcriptase inhibitors. International Journal of Immunotherapy 10: 145-158.
6. De Clercq E (1995) Antiviral therapy for human immunodeficiency virus infections. Clinical Microbiology Reviews 8: 200-239.
7. Heinisch G (1973) Synthesen und Reaktionen von Pyridazinderivaten. Monatshefte für Chemie 104: 953-962.
8. Heinisch G, Matuszczak B & Mereiter K (1997a) A novel 1,2-diazine containing tricyclic system: synthesis of pyridazino-[3,4-b][1,5]benzodiazepin-5-ones as potential HIV-1 reverse transcriptase inhibitors. Heterocycles 45: 673-682.
9. Heinisch G, Huber E, Matuszczak B, Maurer A & Prillinger U (1997b) Synthesis of pyridazino[3,4-b][1,5]benzodiazepin-5-ones and their biological evaluation as non-nucleoside HIV reverse transcriptase inhibitors. Archiv der Pharmazie-Pharmaceutical and Medicinal Chemistry 330: 29-34.
10. Kelly TA, Proudfoot JR, McNeil DW, Patel UR, David E, Hargrave KD, Grob PM, Cardozo M, Agarwal A & Adams J (1995) Novel non-nucleoside inhibitors of human immunodeficiency virus type 1 reverse transcriptase. 5. 4-Substituted and 2,4-disubstituted analogs of nevirapine. Journal of Medicinal Chemistry 38: 4839-4847.
11. Kohlstaedt LA, Wang J, Friedman JM, Rice PA & Steitz TA (1992) Crystal structure at 3.5 Å resolution of HIV-1 reverse transcriptase complexed with an inhibitor. Science 256: 1783-1790.
12. Proudfoot JR, Hargrave KD, Kapadia SR, Patel UR, Grozinger KG, McNeil DW, Cullen E, Cardozo M, Tong L, Kelly TA, Rose J, David E, Mauldin SC, Fuchs VU, Vitous J, Hoermann MA, Klunder JM, Raghavan P, Skiles JW, Mui P, Richman DD, Sullivan JL, Shih C-K, Grob PM & Adams J (1995) Novel non-nucleoside inhibitors of human immunodeficiency virus type 1 (HIV-1) reverse transcriptase. 4. 2-Substituted dipyridodiazepinones as potent inhibitors of both wild-type and cysteine-181 HIV-1 reverse transcriptase enzymes. Journal of Medicinal Chemistry 38: 4830-4838.
13. Ried W & Eichhorn TA (1988) Synthese neuer potentiell analgetisch bzw. antibiotisch wirksamer Pyridazino[4, 3-e][1, 3]-oxazinone und Pyrimido[4, 5-c]pyridazinone. Archives der Pharmazie (Weinheim) 321: 527-532.
14. Smerdon SJ, Jäger J, Wang J, Kohlstaedt LA, Chirino AJ, Frieman JM, Rice PA & Steitz TA (1994) Structure of the bindung site for nonnucleoside inhibitors of the reverse transcriptase of human immunodeficiency virus type 1. Proceedings of the National Academy of Sciences, USA 91: 3911-3915.
15. Wu JC, Warren TC, Adams J, Proudfoot J, Skiles J, Raghavan P, Perry C, Potocki I, Farina PR & Grob PM (1991) A novel dipyridodiazepinone inhibitor of HIV-1 reverse transcriptase acts through a nonsubstrate binding site. Biochemistry 30: 2022-2026.